Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Carmen Fernández M, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R (2006) Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology 44(6):1581–1588. https://doi.org/10.1002/hep.21424

Article  CAS  PubMed  Google Scholar 

Ballatori N, Christian WV, Lee JY, Dawson PA, Soroka CJ, Boyer JL, Madejczyk MS, Li N (2005) OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42(6):1270–1279. https://doi.org/10.1002/hep.20961

Article  CAS  PubMed  Google Scholar 

Begley DJ (2004) Efflux mechanisms in the central nervous system: a powerful influence on drug distribution within the brain. In: Sharma HS, Westman J (eds) Blood-spinal cord and brain barriers in health and disease. Elsevier, Amsterdam, pp 83–97. https://doi.org/10.1016/B978-012639011-7/50013-9

Chapter  Google Scholar 

Camenisch G (2019) Extended Clearance Model and its use for prospective transporter and enzyme-based hepatic cell stress grading. Int J Pharm Chem 5(2):15–19. https://doi.org/10.11648/j.ijpc.20190502.11

Article  CAS  Google Scholar 

Chan R, Benet LZ (2018) Measures of BSEP inhibition in vitro are not useful predictors of DILI. Toxicol Sci 162(2):499–508. https://doi.org/10.1093/toxsci/kfx284

Article  CAS  PubMed  Google Scholar 

Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 21(4):648–653. https://doi.org/10.1016/j.drudis.2016.02.015

Article  CAS  PubMed  Google Scholar 

Chiang JY (2003) Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284(3):G349–G356. https://doi.org/10.1152/ajpgi.00417.2002

Article  CAS  PubMed  Google Scholar 

Chiang JY (2009) Bile acids: regulation of synthesis. J Lipid Res 50(10):1955–1966. https://doi.org/10.1194/jlr.R900010-JLR200

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dawson S, Stahl S, Paul N, Barber J, Kenna JG (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40(1):130–138. https://doi.org/10.1124/dmd.111.040758

Article  CAS  PubMed  Google Scholar 

Dixon PH, van Mil SW, Chambers J, Strautnieks S, Thompson RJ, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson L-A, Marschall H-U, Molokhia M, Moore GE, Linton KJ, Williamson C (2009) Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58(4):537–544. https://doi.org/10.1136/gut.2008.159541

Article  CAS  PubMed  Google Scholar 

Dodge Y (2008) Spearman rank correlation coefficient. In: Dodge Y (ed) The concise encyclopedia of statistics. Springer, New York, NY, pp 502–505. https://doi.org/10.1007/978-0-387-32833-1_379

Chapter  Google Scholar 

Fahmi OA, Maurer TS, Kish M, Cardenas E, Boldt S, Nettleton D (2008) A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro. Drug Metab Dispos 36(8):1698–1708. https://doi.org/10.1124/dmd.107.018663

Article  CAS  PubMed  Google Scholar 

Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273(16):10046–10050. https://doi.org/10.1074/jbc.273.16.10046

Article  CAS  PubMed  Google Scholar 

He K, Cai L, Shi Q, Liu H, Woolf TF (2015) Inhibition of MDR3 activity in human hepatocytes by drugs associated with liver injury. Chem Res Toxicol 28(10):1987–1990. https://doi.org/10.1021/acs.chemrestox.5b00201

Article  CAS  PubMed  Google Scholar 

Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y (2000) ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275(4):2905–2910. https://doi.org/10.1074/jbc.275.4.2905

Article  CAS  PubMed  Google Scholar 

Jansen TL, Reinders MK, van Roon EN, Brouwers JR (2004) Benzbromarone withdrawn from the European market: another case of “absence of evidence is evidence of absence”? Clin Exp Rheumatol 22(5):651

PubMed  Google Scholar 

Kastrinou Lampou V, Poller B, Huth F, Fischer A, Kullak-Ublick GA, Arand M, Schadt HS, Camenisch G (2022) Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes. Toxicol in Vitro 87:105533. https://doi.org/10.1016/j.tiv.2022.105533

Article  CAS  PubMed  Google Scholar 

Kock K, Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KL (2014) Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. Drug Metab Dispos 42(4):665–674. https://doi.org/10.1124/dmd.113.054304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroll T, Smits SHJ, Schmitt L (2021) Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3. J Lipid Res 62:100087. https://doi.org/10.1016/j.jlr.2021.100087

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubitz R, Keitel V, Scheuring S, Kohrer K, Haussinger D (2006) Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 40(2):171–175. https://doi.org/10.1097/01.mcg.0000196406.15110.60

Article  PubMed  Google Scholar 

Mahagita C, Grassl SM, Piyachaturawat P, Ballatori N (2007) Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. Am J Physiol Gastrointest Liver Physiol 293(1):G271–G278. https://doi.org/10.1152/ajpgi.00075.2007

Article  CAS  PubMed  Google Scholar 

Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, Fattinger K (2005) Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol 61(2):135–143. https://doi.org/10.1007/s00228-004-0888-z

Article  PubMed  Google Scholar 

Nakayama S, Atsumi R, Takakusa H, Kobayashi Y, Kurihara A, Nagai Y, Nakai D, Okazaki O (2009) A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab Dispos 37(9):1970–1977. https://doi.org/10.1124/dmd.109.027797

Article  CAS  PubMed  Google Scholar 

Nies AT, Keppler D (2007) The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 453(5):643–659. https://doi.org/10.1007/s00424-006-0109-y

Article  CAS  PubMed  Google Scholar 

Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32(1):56–67. https://doi.org/10.1006/rtph.2000.1399

Article  CAS  PubMed  Google Scholar 

Poller B, Huth F, Kastrinou-Lampou V, Kullak-Ublick GA, Arand M, Camenisch G (2021) The extended clearance model. In: Li AP (ed) Transporters and drug-metabolizing enzymes in drug toxicity. Wiley, Hoboken, NJ, pp 455–479. https://doi.org/10.1002/9781119171003.ch15

Chapter  Google Scholar 

Rendic SP, Peter Guengerich F (2018) Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits. Drug Metab Rev 50(3):256–342. https://doi.org/10.1080/03602532.2018.1483401

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riede J, Poller B, Huwyler J, Camenisch G (2017) Assessing the risk of drug-induced cholestasis using unbound intrahepatic concentrations. Drug Metab Dispos 45(5):523–531. https://doi.org/10.1124/dmd.116.074179

Article